TDOC Teladoc Health, Inc.
Healthcare$6.59+0.30%ClosedMarket Cap: $1.19B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.88
P/S
0.47
EV/EBITDA
22.89
DCF Value
$18.45
FCF Yield
21.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
65.6%
Operating Margin
-7.6%
Net Margin
-6.8%
ROE
-12.4%
ROA
-6.1%
ROIC
-7.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $613.8M | 52.8% | $-48.7M | $-63.8M | $— | — |
| Q4 null | $642.3M | 69.3% | $-36.0M | $-25.1M | $— | — |
| FY null | $2.53B | 69.5% | $-263.0M | $-200.3M | $— | — |
| Q3 null | $626.4M | 70.1% | $-52.0M | $-49.5M | $— | — |
| Q2 null | $631.9M | 69.8% | $-54.4M | $-32.7M | $— | — |
| Q1 null | $629.4M | 68.7% | $-120.6M | $-93.0M | $— | — |
| Q4 null | $640.5M | 70.5% | $-48.2M | $-48.4M | $— | — |
| FY null | $2.57B | 70.8% | $-1.02B | $-1.00B | $— | — |
| Q3 null | $640.5M | 71.9% | $-44.4M | $-33.3M | $— | — |
| Q2 null | $642.4M | 70.7% | $-841.1M | $-837.7M | $— | — |
| Q1 null | $646.1M | 69.9% | $-87.1M | $-81.9M | $— | — |
| Q4 2023 | $660.5M | 70.7% | $-35.1M | $-28.9M | $-0.17 | — |